CD4 and asthma: Defining the mechanisms by which altered ORMDL3 expression perturbs CD4+ T cell differentiation and function should illuminate new treatment paradigms for patients with 17q12–21 risk SNPs, and expand of our current understanding of asthma pathogenesis.